BVX — Bivictrix Therapeutics Share News
0.000.00%
Last trade - 00:00- £6.19m
- £4.70m
REG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - BiVictriX Hosts Inaugural Roundtable Discussion
AnnouncementREG - BiVictriX Therapcts. - Board Change
AnnouncementREG - BiVictriX Therapcts. - Pipeline update on BVX002
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Patent Granted in Japan
AnnouncementREG - BiVictriX Therapcts. - Extended Survival Rates Reported with BVX001
AnnouncementREG - BiVictriX Therapcts. - Appointment of Adrian Howd as CFO and CBO
AnnouncementREG - BiVictriX Therapcts. - Interim Results
AnnouncementREG - BiVictriX Therapcts. - Total Voting Rights
AnnouncementREG - BiVictriX Therapcts. - US Patent Granted
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Holding(s) in Company
AnnouncementREG - BiVictriX Therapcts. - Result of General Meeting
AnnouncementREG - BiVictriX Therapcts. - Result of Conditional Fundraise
AnnouncementREG - BiVictriX Therapcts. - Proposed Fundraise in excess of £2 million
AnnouncementREG - BiVictriX Therapcts. - Positive final data in preclinical efficacy study
AnnouncementREG - BiVictriX Therapcts. - Positive interim data
Announcement